Raschi, E.; Nannini, M.; Montastruc, F.; Khouri, C.; Poluzzi, E.; De Ponti, F., Anticancer drugs and depression through the lens of disproportionality analysis: unveiling underlying confounders and tips for prescribers, «JOURNAL OF AFFECTIVE DISORDERS», 2026, 399, pp. 1 - 2 [Scientific article]
Raschi, E.; Tonetti, T.; Khouri, C.; Poluzzi, E.; De Ponti, F., Contemporary local anaesthetic-associated adverse events and mortality: searching for the root causes of the pharmacovigilance signal. Br J Anaesth 2026;136:411–13, «BRITISH JOURNAL OF ANAESTHESIA», 2026, 136, pp. 408 - 410 [Comment or similar]
Donker, E. M.; Piët, J. D.; Brinkman, D. J.; Richir, M. C.; Papaioannidou, P.; Likic, R.; Sanz, E. J.; Christiaens, T.; Costa, J. N.; De Ponti, F.; Gatti, M.; Böttiger, Y.; Kramers, C.; Van Agtmael, M. A.; Tichelaar, J., Barriers and solutions for the European prescribing exam: a qualitative world café study, «EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY», 2025, 81, pp. 1451 - 1459 [Scientific article]Open Access
Procacci, Angela; Poluzzi, Elisabetta; De Ponti, Fabrizio; Raschi, Emanuel, Disproportionality analysis on semaglutide and nonarteritic anterior ischemic optic neuropathy in the FDA adverse event reporting system: An emerging pharmacovigilance signal?, «OBESITY RESEARCH & CLINICAL PRACTICE», 2025, 19, pp. 178 - 180 [Scientific article]
Donati, Monia; Boccia, Angela; De Ponti, Fabrizio; Poluzzi, Elisabetta; Raschi, Emanuel, Long-term surveillance of the anti-amyloid monoclonal antibody lecanemab: rights and duties of pharmacovigilance, «ALZHEIMER'S RESEARCH & THERAPY», 2025, 17, Article number: 80 , pp. 1 - 4 [Scientific article]Open Access
Nocera, Domenico; Forastiero, Giusi; Logreco, Andrea; Proietti, Alessia; Galluccio, Antonio; Lunghi, Carlotta; Poluzzi, Elisabetta; De Ponti, Fabrizio, Toward the harmonization of bioequivalence guidelines in Europe: Commentary on the state of the art and future priorities under ICH M13A for immediate‐release oral forms, «BRITISH JOURNAL OF CLINICAL PHARMACOLOGY», 2025, Online ahead of print., pp. 1 - 5 [Scientific article]Open Access
Lunghi C.; Domenicali M.; Vertullo S.; Raschi E.; De Ponti F.; Onder G.; Poluzzi E., Adopting STOPP/START Criteria Version 3 in Clinical Practice: A Q&A Guide for Healthcare Professionals, «DRUG SAFETY», 2024, 47, pp. 1061 - 1074 [Scientific article]Open Access
Cecco, S.; Puligheddu, S.; Fusaroli, M.; Gerratana, L.; Yan, M.; Zamagni, C.; De Ponti, F.; Raschi, E., Emerging Toxicities of Antibody-Drug Conjugates for Breast Cancer: Clinical Prioritization of Adverse Events from the FDA Adverse Event Reporting System, «TARGETED ONCOLOGY», 2024, 19, pp. 435 - 445 [Scientific article]
Hartjes, M. G.; Richir, M. C.; Cazaubon, Y.; Donker, E. M.; van Leeuwen, E.; Likic, R.; Pers, Y. M.; Piët, J. D.; De Ponti, F.; Raasch, W.; van Rosse, F.; Rychlícková, J.; Sanz, E. J.; Schwaninger, M.; Wallerstedt, S. M.; de Vries, T. P. G. M.; van Agtmael, M. A.; Tichelaar, J., Enhancing therapeutic reasoning: key insights and recommendations for education in prescribing, «BMC MEDICAL EDUCATION», 2024, 24, Article number: 1360 , pp. 1 - 14 [Scientific article]Open Access
Piët, J. D.; Booth, A.; Donker, E. M.; de Ponti, F.; Lunghi, C.; Poluzzi, E.; Janssen, B. J. A.; Tun, S. Y. M.; Bekker, C.; Dima, L.; Costa, J.; Jalving, M.; Oude Munnink, T. H.; van den Bemt, P. M. L. A.; Labriffe, M.; van Emden, T.; van Waardenburg, V.; Likic, R.; Richir, M.; van Agtmael, M. A.; Moermond, C. T. A.; Tichelaar, J., Environmentally sustainable prescribing: recommendations for EU pharmaceutical legislation, «THE LANCET. PLANETARY HEALTH», 2024, 8, pp. 715 - 716 [Comment or similar]
Colonnello, Valentina; Zodl, Aurelia; Agnoletti, Davide; Lischeid, Kilian; Cimbalnik, Lena; Weidenbusch, Marc; R Fischer, Martin; De Ponti, Fabrizio; Rausch, Christian, Implementing Clinical Case Discussions to Enhance Clinical Reasoning Skills: A Pilot Study in an Italian Medical School, «INTERNATIONAL MEDICAL EDUCATION», 2024, 3, pp. 306 - 315 [Scientific article]Open Access
Poluzzi E.; Raschi E.; Lunghi C.; Bertuccio A.; Eleftheriou A.; De Ponti F., Learning of clinical pharmacology by future prescribers in Bologna: Teachers' and students' reflections on the way forward, «BRITISH JOURNAL OF CLINICAL PHARMACOLOGY», 2024, 2024, pp. 1 - 8 [Scientific article]
Fusaroli, M.; Khouri, C.; Poluzzi, E.; De Ponti, F.; Salvo, F.; Raschi, E., Meta-analyzing Results From Disproportionality Analysis of Individual Case Safety Reports A Note of Caution, «JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY», 2024, 44, pp. 443 - 444 [Scientific article]
Raschi, E.; Salvo, F.; Bate, A.; De Ponti, F.; Poluzzi, E.; Tuccori, M.; van Puijenbroek, E.; Joshi, N.; Khouri, C., Peer Review in Pharmacovigilance: Lens on Disproportionality Analysis, «DRUG SAFETY», 2024, 47, pp. 601 - 605 [Comment or similar]
Donker, Erik M; Spitaleri Timpone, Pietro; Brinkman, David J; Richir, Milan C; Papaioannidou, Paraskevi; Likic, Robert; Sanz, Emilio J; Christiaens, Thierry; Costa, João N; De Ponti, Fabrizio; Gatti, Milo; Böttiger, Ylva; Kramers, Cornelis; Pandit, Rahul; van Agtmael, Michiel A; Tichelaar, Jelle, The European List of Key Medicines for Medical Education: A Modified Delphi Study, «CLINICAL PHARMACOLOGY & THERAPEUTICS», 2024, 115, pp. 515 - 524 [Scientific article]Open Access
